Digital technologies in the public-health response to COVID-19

Jobie Budd; Benjamin S. Miller; Erin M. Manning; Vasileios Lampos; Mengdie Zhuang; Michael Edelstein; Geraint Rees; Vincent C. Emery; Molly M. Stevens; Neil Keegan; Michael J. Short; Deenan Pillay; Ed Manley; Ingemar J. Cox; David Heymann; Anne M. Johnson; Rachel A. McKendry

doi:https://doi.org/10.1038/s41591-020-1011-4

Digital technologies in the public-health response to COVID-19

Jobie Budd, Benjamin S. Miller, Erin M. Manning, Vasileios Lampos, Mengdie Zhuang, Michael Edelstein, Geraint Rees, Vincent C. Emery, Molly M. Stevens, Neil Keegan, Michael J. Short, Deenan Pillay, Ed Manley, Ingemar J. Cox, David Heymann, Anne M. Johnson, Rachel A. McKendry

Research output: Contribution to journal › Review article › peer-review

Abstract

Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.

Original language	English
Pages (from-to)	1183-1192
Number of pages	10
Journal	Nature Medicine
Volume	26
Issue number	8
DOIs	https://doi.org/10.1038/s41591-020-1011-4
State	Published - 1 Aug 2020
Externally published	Yes

All Science Journal Classification (ASJC) codes

General Biochemistry,Genetics and Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1038/s41591-020-1011-4

Cite this

Budd, J., Miller, B. S., Manning, E. M., Lampos, V., Zhuang, M., Edelstein, M., Rees, G., Emery, V. C., Stevens, M. M., Keegan, N., Short, M. J., Pillay, D., Manley, E., Cox, I. J., Heymann, D., Johnson, A. M., & McKendry, R. A. (2020). Digital technologies in the public-health response to COVID-19. Nature Medicine, 26(8), 1183-1192. https://doi.org/10.1038/s41591-020-1011-4

@article{abda9bf0d5744fc990b5364f8c6b93d5,

title = "Digital technologies in the public-health response to COVID-19",

abstract = "Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.",

author = "Jobie Budd and Miller, {Benjamin S.} and Manning, {Erin M.} and Vasileios Lampos and Mengdie Zhuang and Michael Edelstein and Geraint Rees and Emery, {Vincent C.} and Stevens, {Molly M.} and Neil Keegan and Short, {Michael J.} and Deenan Pillay and Ed Manley and Cox, {Ingemar J.} and David Heymann and Johnson, {Anne M.} and McKendry, {Rachel A.}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Nature America, Inc.",

year = "2020",

month = aug,

day = "1",

doi = "https://doi.org/10.1038/s41591-020-1011-4",

language = "الإنجليزيّة",

volume = "26",

pages = "1183--1192",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "8",

}

TY - JOUR

T1 - Digital technologies in the public-health response to COVID-19

AU - Budd, Jobie

AU - Miller, Benjamin S.

AU - Manning, Erin M.

AU - Lampos, Vasileios

AU - Zhuang, Mengdie

AU - Edelstein, Michael

AU - Rees, Geraint

AU - Emery, Vincent C.

AU - Stevens, Molly M.

AU - Keegan, Neil

AU - Short, Michael J.

AU - Pillay, Deenan

AU - Manley, Ed

AU - Cox, Ingemar J.

AU - Heymann, David

AU - Johnson, Anne M.

AU - McKendry, Rachel A.

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.

AB - Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=85089188396&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41591-020-1011-4

DO - https://doi.org/10.1038/s41591-020-1011-4

M3 - مقالة مرجعية

C2 - 32770165

SN - 1078-8956

VL - 26

SP - 1183

EP - 1192

JO - Nature Medicine

JF - Nature Medicine

IS - 8

ER -

Digital technologies in the public-health response to COVID-19

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this